The director of the Stroke Center at Banner-University Medicine Neuroscience Institute spoke to the need for data like that from the TELECAST study and how the COVID-19 pandemic might push telestroke care forward.
Jeremy Payne, MD, PhD
Advertisement
Articles by Jeremy Payne, MD, PhD
The director of the Stroke Center at Banner-University Medicine Neuroscience Institute discussed how data from the TELECAST trial impact existing literature and the areas of improvement for the current use of telemedicine for stroke.
Advertisement
Latest Updated Articles
Jeremy Payne, MD, PhD: The Need to Improve Telestroke CarePublished: May 4th 2020 | Updated:
- Jeremy Payne, MD, PhD: The Lack of Progress for Telestroke
Published: May 6th 2020 | Updated:
Advertisement
Advertisement
Trending on NeurologyLive - Clinical Neurology News and Neurology Expert Insights
1
Fenebrutinib Hits Key Phase 3 Marks in Relapsing and Primary Progressive MS
2
FDA Clears Phase 2a Clinical Trial to Test JOTROL in Patients With Parkinson Disease
3
OnabotulinumtoxinA Fails to Meet Primary End Point in Phase 3 PRECLUDE Trial for Episodic Migraine
4
Doxecitine/Doxribitine Approval Redefines Care in Thymidine Kinase 2 Deficiency: Fabian Somers, PhD
5
